Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.

Hurnakova J, Hulejova H, Zavada J, Hanova P, Komarc M, Mann H, Klein M, Sleglova O, Olejarova M, Forejtova S, Ruzickova O, Vencovsky J, Pavelka K, Senolt L.

PLoS One. 2017 Aug 23;12(8):e0183420. doi: 10.1371/journal.pone.0183420. eCollection 2017.

2.

Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis.

Šenolt L, Prajzlerová K, Hulejová H, Šumová B, Filková M, Veigl D, Pavelka K, Vencovský J.

Cytokine. 2017 Sep;97:187-192. doi: 10.1016/j.cyto.2017.06.009. Epub 2017 Jun 26.

PMID:
28662439
3.
4.

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.

Hurnakova J, Hulejova H, Zavada J, Komarc M, Hanova P, Klein M, Mann H, Sleglova O, Olejarova M, Forejtova S, Ruzickova O, Vencovsky J, Pavelka K, Senolt L.

PLoS One. 2016 Nov 10;11(11):e0165498. doi: 10.1371/journal.pone.0165498. eCollection 2016.

5.

Effect of Blood Component Coatings of Enosseal Implants on Proliferation and Synthetic Activity of Human Osteoblasts and Cytokine Production of Peripheral Blood Mononuclear Cells.

Himmlova L, Kubies D, Hulejova H, Bartova J, Riedel T, Stikarova J, Suttnar J, Pesakova V.

Mediators Inflamm. 2016;2016:8769347. doi: 10.1155/2016/8769347. Epub 2016 Aug 29.

6.

Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients.

Hulejová H, Kryštůfková O, Mann H, Klein M, Pavlíčková K, Zámečník J, Vencovský J, Šenolt L.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):222-9. Epub 2016 Feb 9.

PMID:
26886056
7.

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.

Závada J, Uher M, Svobodová R, Olejárová M, Hušáková M, Ciferská H, Hulejová H, Tomčík M, Šenolt L, Vencovský J.

Arthritis Res Ther. 2015 Nov 25;17:341. doi: 10.1186/s13075-015-0862-4.

8.

Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.

Hurnakova J, Zavada J, Hanova P, Hulejova H, Klein M, Mann H, Sleglova O, Olejarova M, Forejtova S, Ruzickova O, Komarc M, Vencovsky J, Pavelka K, Senolt L.

Arthritis Res Ther. 2015 Sep 15;17:252. doi: 10.1186/s13075-015-0764-5.

9.

Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis.

Cerezo LA, Kuklová M, Hulejová H, Vernerová Z, Kaspříková N, Veigl D, Pavelka K, Vencovský J, Šenolt L.

Mediators Inflamm. 2015;2015:740357. doi: 10.1155/2015/740357. Epub 2015 Aug 3.

10.

Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.

Tomcik M, Zerr P, Palumbo-Zerr K, Storkanova H, Hulejova H, Spiritovic M, Kodet O, Stork J, Becvar R, Vencovsky J, Pavelka K, Filkova M, Distler JH, Senolt L.

Rheumatology (Oxford). 2015 Dec;54(12):2273-82. doi: 10.1093/rheumatology/kev260. Epub 2015 Jul 31.

PMID:
26231346
11.

Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis.

Šenolt L, Šumová B, Jandová R, Hulejová H, Mann H, Pavelka K, Vencovský J, Filková M.

PLoS One. 2015 Jul 23;10(7):e0132674. doi: 10.1371/journal.pone.0132674. eCollection 2015.

12.

Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis.

Filková M, Vernerová Z, Hulejová H, Prajzlerová K, Veigl D, Pavelka K, Vencovský J, Šenolt L.

Cytokine. 2015 May;73(1):36-43. doi: 10.1016/j.cyto.2015.01.019. Epub 2015 Feb 16.

PMID:
25697137
13.

Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort.

Sglunda O, Mann H, Hulejová H, Kuklová M, Pecha O, Pleštilová L, Filková M, Pavelka K, Vencovský J, Senolt L.

PLoS One. 2014 Jul 28;9(7):e103495. doi: 10.1371/journal.pone.0103495. eCollection 2014.

14.

Decrease in serum interleukin-21 levels is associated with disease activity improvement in patients with recent-onset rheumatoid arthritis.

Sglunda O, Mann HF, Hulejová H, Pecha O, Pleštilová L, RůŽičková O, Fojtíková M, Sléglová O, Forejtová S, Pavelka K, Vencovský J, Senolt L.

Physiol Res. 2014;63(4):475-81. Epub 2014 Apr 3.

15.

Early changes in serum visfatin after abdominal surgery: a new pro-inflammatory marker in diagnosis?

Teplan V, Senolt L, Hulejova H, Teplan V, Stollova M, Gurlich R.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Sep;159(3):489-96. doi: 10.5507/bp.2014.012. Epub 2014 Mar 10.

16.

[Dynamics of serum visfatin level after abdominal surgery: a new proinflammatory marker in the early diagnosis?].

Teplan V Jr, Šenolt L, Hulejová H, Teplan V, Štollová M, Gürlich R.

Cas Lek Cesk. 2013;152(5):226-32. Czech.

PMID:
24131460
17.

The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.

Andrés Cerezo L, Kuklová M, Hulejová H, Vernerová Z, Pešáková V, Pecha O, Veigl D, Haluzík M, Pavelka K, Vencovský J, Senolt L.

Cytokine. 2013 Oct;64(1):441-7. doi: 10.1016/j.cyto.2013.05.001. Epub 2013 May 25.

PMID:
23714112
18.

Novel adipokine fibroblast growth factor 21 is increased in rheumatoid arthritis.

Hulejová H, Andrés Cerezo L, Kuklová M, Pecha O, Vondráček T, Pavelka K, Vencovský J, Haluzík M, Senolt L.

Physiol Res. 2012;61(5):489-94. Epub 2012 Aug 8.

19.

Pentosidine, an advanced glycation end-product, may reflect clinical and morphological features of hand osteoarthritis.

Braun M, Hulejová H, Gatterová J, Filková M, Pavelková A, Sléglová O, Kaspříková N, Vencovský J, Pavelka K, Senolt L.

Open Rheumatol J. 2012;6:64-9. doi: 10.2174/1874312901206010064. Epub 2012 Jun 1.

20.

Resistin in idiopathic inflammatory myopathies.

Filková M, Hulejová H, Kuncová K, Pleštilová L, Cerezo LA, Mann H, Klein M, Zámečník J, Gay S, Vencovský J, Senolt L.

Arthritis Res Ther. 2012 May 11;14(3):R111. doi: 10.1186/ar3836.

Supplemental Content

Loading ...
Support Center